SLC32A1新发错义变异通过损害GABA能神经传递导致发育性癫痫性脑病
该研究通过外显子测序在4名发育性癫痫性脑病患者中鉴定出SLC32A1新发错义变异,并在小鼠神经元培养模型中功能验证。主要表型为中度至重度智力障碍、婴儿期起病癫痫及舞蹈样/肌张力障碍/运动障碍。变异通过影响突触囊泡GABA填充或改变突触短时程可塑性损害GABA能传递,确立SLC32A1为新病因。
要点
- SLC32A1新发错义变异可导致发育性癫痫性脑病,表型包括智力障碍、婴儿期癫痫和运动障碍。
- 功能研究显示变异通过减少量子大小或增加突触前释放概率损害GABA能传递。
- 该发现扩展了GABA相关癫痫的遗传病因和病理机制。
核心结论
- SLC32A1新发错义变异是发育性癫痫性脑病的新病因,通过至少两种机制损害GABA能神经传递。
研究设计与样本
- 使用外显子测序鉴定4名携带SLC32A1新发错义变异的发育性癫痫性脑病患者。
- 在小鼠神经元细胞培养模型中对鉴定出的变异进行功能评估。
- 采用计算机模拟建模分析变异的结构影响。
主要发现
- 主要表型包括中度至重度智力障碍、生后18个月内起病的婴儿期癫痫以及舞蹈样、肌张力障碍性或运动障碍性运动障碍。
- 位于推测GABA转运通路螺旋上的三个变异导致量子大小降低,符合突触囊泡GABA填充受损。
- 位于囊泡γ-氨基丁酸N端的第四个变异不影响量子大小,但增加突触前释放概率,导致高频刺激下更严重的突触抑制。
临床怎么用
- 作者认为SLC32A1变异是神经发育障碍伴癫痫的新遗传病因和新的GABA相关疾病机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rare inherited missense variants in SLC32A1, the gene that encodes the vesicular gamma-aminobutyric acid (GABA) transporter, have recently been shown to cause genetic epilepsy with febrile seizures plus. We aimed to clarify if de novo missense variants in SLC32A1 can also cause epilepsy with impaired neurodevelopment. METHODS: Using exome sequencing, we identified four individuals with a developmental and epileptic encephalopathy and de novo missense variants in SLC32A1. To assess causality, we performed functional evaluation of the identified variants in a murine neuronal cell culture model. RESULTS: The main phenotype comprises moderate-to-severe intellectual disability, infantile-onset epilepsy within the first 18 months of life, and a choreiform, dystonic, or dyskinetic movement disorder. In silico modeling and functional analyses reveal that three of these variants, which are located in helices that line the putative GABA transport pathway, result in reduced quantal size, consistent with impaired filling of synaptic vesicles with GABA. The fourth variant, located in the vesicular gamma-aminobutyric acid N-terminus, does not affect quantal size, but increases presynaptic release probability, leading to more severe synaptic depression during high-frequency stimulation. Thus, variants in vesicular gamma-aminobutyric acid can impair GABAergic neurotransmission through at least two mechanisms, by affecting synaptic vesicle filling and by altering synaptic short-term plasticity. INTERPRETATION: This work establishes de novo missense variants in SLC32A1 as a novel cause of a developmental and epileptic encephalopathy. SUMMARY FOR SOCIAL MEDIA IF PUBLISHED: @platzer_k @lemke_johannes @RamiJamra @Nirgalito @GeneDx The SLC family 32 Member 1 (SLC32A1) is the only protein identified to date, that loads gamma-aminobutyric acid (GABA) and glycine into synaptic vesicles, and is therefore also known as the vesicular GABA transporter (VGAT) or vesicular inhibitory amino acid transporter (VIAAT). Rare inherited missense variants in SLC32A1, the gene that encodes VGAT/vesicular inhibitory amino acid transporter, have recently been shown to cause genetic epilepsy with febrile seizures plus. We aimed to clarify if de novo missense variants in SLC32A1 can also cause epilepsy with impaired neurodevelopment. We report on four individuals with de novo missense variants in SLC32A1 and a developmental and epileptic encephalopathy with infantile onset epilepsy. We establish causality of the variants via in silico modeling and their functional evaluation in a murine neuronal cell culture model. SLC32A1 variants represent a novel genetic etiology in neurodevelopmental disorders with epilepsy and a new GABA-related disease mechanism. ANN NEUROL 2022;92:958-973.
引用
- Platzer K, Sticht H, Bupp C, et al. De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission. Ann Neurol. 2022. PMID: 36073542. doi:10.1002/ana.26485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。